Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @mollypurser_HE
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @mollypurser_HE
-
Great to see this innovation and cooperation!
#genetherapy @RTIHS Cigna Health Services Business Pioneers an Innovative Solution to Affordably Bring Life-Changing Therapies to Patients | BioSpacehttps://www.biospace.com/article/releases/cigna-health-services-business-pioneers-an-innovative-solution-to-affordably-bring-life-changing-therapies-to-patients/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Rare disease modeling considerations from Chris Knight
@RTIHS: disease complexity, clinical benefit, patient and caregiver burden#ISPORannual#HEOR#RareDiseasepic.twitter.com/KvWqxIXmSO
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Looking forward the the rare diseases Educational Symposium!
@RTIHS@ISPORorgpic.twitter.com/uUKBIPgcYf
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Agree with Dr. Azam start ups need to think about market access and reimbursement in Phase 1.
@usmanazam#regenerativemedicine#GeneTherapy#drugprices @RTIHShttps://www.fiercepharma.com/pharma/alternative-payment-models-to-reset-paradigm-for-reimbursement-gene-and-cell-therapies?mkt_tok=eyJpIjoiTXpnMU1tUmlNMlUyTkRjNSIsInQiOiJGQjFvTXR5TTBIQzRTQ0wreTZcL3lMZlNGVTJ4R3pneEpIOEdyWGl5XC9MWDhjTHBnbFRFYXgrdkVhUjBYNHhwVzljXC84cU5BOG9BaGZMMzRoU1NYK0Yzb1Nia0ZXaVwvUjdkS1wvNkVpVjJHU292Syt0NW1KbzN6MnVXRldwaHd5Y0tvIn0%3D&mrkid=26963933&utm_medium=nl&utm_source=internal …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Statement from FDA Commissioner Scott Gottlieb, M.D. and Peter Marks, M.D., Ph.D., Director of the Center for Biologics Evaluation and Research on new policies to advance development of safe and effective cell and gene therapieshttps://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm629493.htm …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
HEOR implications of the differences in
#RegenMed need to be considered#celltherapy#genetherapy#tissueengineering#HEORhttps://twitter.com/RTIHS/status/1062683540297580544 …
1:49Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Wonderful session to end
#ISPORBarcelona. Great to hear a payer perspective, especially on indication-based pricing for#RegenMed Would like to see this type of panel in New Orleans@ISPORorg@MichealEpstein@RTIHSpic.twitter.com/cmwjhfajjq
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
More potentially
#curative therapies are in the pipeline, great to hear this discussion. Potential differences in the therapies and therapeutic area may result in different answers to these questions.#ISPORBarcelona#RegenerativeMedicine@ISPORorghttps://twitter.com/ISPORorg/status/1062335058244177920 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
@JensGrueger provided great points on valuing a cure vs a chronic treatment at
#ISPORbarcelona spotlight session@ISPORorg@RTIHSpic.twitter.com/cMWizavEc2
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Great discussion at
#ISPORbarcelona on expanding the Precision/Personalized Medicine SIG to include#RegenerativeMedicine@RTIHS@ISPORorg@EricFaulknerHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Presenting our poster this morning @ISPORBarcelona on a regenerative medicine classification for HEOR
#Genetherapy#celltherapy#tissueengineering#HEOR@RTIHSpic.twitter.com/Drhyk2uhhc
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Looking forward to the ISPOR Summit today on value assessment
#Summit2018#ISPOR#HEOR@RTIHS@ISPORorgpic.twitter.com/lSUpNL7SsO
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Economic model estimated reduction in hospital costs was a main driver
#epilepsy#VNS#DrugResistantEpilepsy@LivaNovahttps://twitter.com/RTIHS/status/1052528423917248513 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hope we can move to global harmonization
#regenmed#cellTherapy#genethearpyhttps://twitter.com/SCBRegenMed/status/1050819695237103616 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Great news for these patients. Looking forward to following the progress of this novel
#celltherapy#cancer#RegMed@RTIHShttps://twitter.com/MaxCyte_info/status/1050402608719032321 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Interesting presentation by @AliBrivanlou on how self-organizing synthetic embryos may one day cure Huntington’s disease at thhe last day of the Alliance for Regenerative Medicine conf
@RTIHS#genomics#genetherapy#RegenerativeMedicine#mesa2018Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Molly Purser proslijedio/la je Tweet
News from the nest! The European Medicines Agency (
@EMA_News) has accepted our marketing authorization application for our investigational gene therapy: http://investor.bluebirdbio.com/news-releases/news-release-details/bluebird-bio-announces-european-medicines-agencys-acceptance …#genetherapypic.twitter.com/CrjcOkmIkR
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Agree! Reimbursement strategy needs to be considered early to ensure these transformative therapies get the patients.
@RTIHS#Mesa2018#celltherapies#GeneTherapyhttps://twitter.com/ScripMandy/status/1047894224899735552 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr. Oz Azam highlights the importance of having a health economic and HTA strategy early in the development of
#Celltherapy and#genetherapy products.#mesa2018#HEOR#HTApic.twitter.com/9NFbteLyCv
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.